Despite progress, women are 'severely underrepresented' in biotech — report
Of the 200 micro- and small-cap biotech CEOs included in the Bedford Group and Transearch’s latest study, only 17, or 8.5%, self-identified as women.
While that marks a nearly 3% improvement from 2020, Bedford Group partner and managing director Darren Raycroft remains “cautiously optimistic.” Of 745 total execs, 18% were female, up from less than 10% in 2020. And on boards, women saw an 11% jump in representation, while minority groups saw a 2% increase.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
